Abstract
Many approaches have been applied in biological and clinical studies aimed at simultaneously monitoring the expression of a large number of genes and at identifying the gene expression patterns associated with specific cell types. In the last decade, microarrays are emerged as an innovative tool to detect differentially expressed genes as disease-specific markers and to cluster the co-expressed genes regulating the molecular interactions. In fact, microarrays have been widely used for tumour diagnosis and classification, prediction of prognoses and treatment, pharmaceutical safety assessment, and understanding of molecular mechanisms, biochemical pathways, and gene networks. Besides the clinical relevance and the wide application of this technology, several problems remain to be addressed. This review illustrates the current and future directions of the microarray platform, and highlights the successes and strengths, as well as the shortcomings and limitations of this technology. An overview of microarray impact on the ocular and craniofacial diseases is provided.
Keywords: Craniofacial diseases, Gene expression, Microarray analysis, Ocular diseases
Current Pharmaceutical Analysis
Title: Microarrays as a Tool for Gene Expression Profiling: Application in Ocular and Craniofacial Research
Volume: 3 Issue: 3
Author(s): Maria Visalli, Mario Venza, Isabella Venza, Claudia Torino and Diana Teti
Affiliation:
Keywords: Craniofacial diseases, Gene expression, Microarray analysis, Ocular diseases
Abstract: Many approaches have been applied in biological and clinical studies aimed at simultaneously monitoring the expression of a large number of genes and at identifying the gene expression patterns associated with specific cell types. In the last decade, microarrays are emerged as an innovative tool to detect differentially expressed genes as disease-specific markers and to cluster the co-expressed genes regulating the molecular interactions. In fact, microarrays have been widely used for tumour diagnosis and classification, prediction of prognoses and treatment, pharmaceutical safety assessment, and understanding of molecular mechanisms, biochemical pathways, and gene networks. Besides the clinical relevance and the wide application of this technology, several problems remain to be addressed. This review illustrates the current and future directions of the microarray platform, and highlights the successes and strengths, as well as the shortcomings and limitations of this technology. An overview of microarray impact on the ocular and craniofacial diseases is provided.
Export Options
About this article
Cite this article as:
Maria Visalli , Mario Venza , Isabella Venza , Claudia Torino and Diana Teti , Microarrays as a Tool for Gene Expression Profiling: Application in Ocular and Craniofacial Research, Current Pharmaceutical Analysis 2007; 3 (3) . https://dx.doi.org/10.2174/157341207781369312
DOI https://dx.doi.org/10.2174/157341207781369312 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Metallothioneins and Cancer
Current Protein & Peptide Science Gene Therapy: Optimising DNA Delivery to the Nucleus
Current Drug Targets Laccases in Pharmaceutical Chemistry: A Comprehensive Appraisal
Mini-Reviews in Organic Chemistry Aberrant Immunoglobulin Variations as Indicators of Eventual Clonal Changes in Symptomatic Multiple Myeloma Patients' Course
Current Cancer Therapy Reviews Germ Cell Apoptosis: Relevance to Infertility and Contraception
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Anticancer Vitamin K3 Analogs: A Review
Anti-Cancer Agents in Medicinal Chemistry Safer Vectors for Gene Therapy of Primary Immunodeficiencies
Current Gene Therapy Toll Like Receptors Signaling Pathways as a Target for Therapeutic Interventions
Current Signal Transduction Therapy Population Diversity and its Relationship with Infectious and Tumor Diseases
Current Immunology Reviews (Discontinued) Accessing Cancer Metabolic Pathways by the Use of Microarray Technology
Current Pharmaceutical Design Human Carbonyl Reductases
Current Drug Metabolism Development of Decision Tree Models for Substrates, Inhibitors, and Inducers of P-Glycoprotein
Current Drug Metabolism Modulating Mitochondria-Mediated Apoptotic Cell Death through Targeting of Bcl-2 Family Proteins
Recent Patents on DNA & Gene Sequences Is DNA Minor Groove Binding Crucial for Biological Activity of Triazoloacridinones with Cytotoxic and Antitumour Properties?
Letters in Drug Design & Discovery Paris polyphylla: Chemical and Biological Prospectives
Anti-Cancer Agents in Medicinal Chemistry Benzophenone Sulfonamide Derivatives as Interacting Partners and Inhibitors of Human P-glycoprotein
Anti-Cancer Agents in Medicinal Chemistry Increased Paternal Age and Child Health and Development
Current Pediatric Reviews Fused Xanthone Derivatives as Antiproliferative Agents
Anti-Cancer Agents in Medicinal Chemistry Antibody-Based Preventive and Therapeutic Strategies Against HIV
Current HIV Research CXCR4 Inhibitors: Tumor Vasculature and Therapeutic Challenges
Recent Patents on Anti-Cancer Drug Discovery